找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drugs and the Liver: High Risk Patients and Transplantation; D. Galmarini,L. R. Fassati,S. Sherlock Book 1993 Springer Science+Business Me

[復(fù)制鏈接]
樓主: 實(shí)體
31#
發(fā)表于 2025-3-27 00:00:39 | 只看該作者
DSC Configuration Delivery Modesration, because it represents a potentially irreversible form of injury, for which there is little available therapy (1). In the recent past, this specific area of investigation has significantly progressed and the molecular biology techniques are the basis for this terrific improvement (2).
32#
發(fā)表于 2025-3-27 05:05:28 | 只看該作者
33#
發(fā)表于 2025-3-27 06:17:08 | 只看該作者
978-94-010-5748-6Springer Science+Business Media Dordrecht 1993
34#
發(fā)表于 2025-3-27 11:41:51 | 只看該作者
Medical Science Symposia Serieshttp://image.papertrans.cn/e/image/283213.jpg
35#
發(fā)表于 2025-3-27 15:38:11 | 只看該作者
36#
發(fā)表于 2025-3-27 20:34:24 | 只看該作者
Risk Assessment in Liver Transplantation Focus on Lung Function, transplanted patients and these organs may fail even when the liver function is acceptable. Renal, hemodynamic and cardiac function, coagulation abnormalities have been extensively investigated in this context while lung function is less frequently addressed.
37#
發(fā)表于 2025-3-27 22:30:02 | 只看該作者
Donor Rating and Assessment of Pretransplant Prognosis by Use of the MEGX Test,formation of the lidocaine metabolite monoethylglycinexylidide (MEGX). This test is rapid and easy to perform. A loss of hepatic cytochrome P-450 activity or major changes of hepatic blood flow, for instance due to portosystemic shunting, result in a decrease of MEGX formation.
38#
發(fā)表于 2025-3-28 05:27:15 | 只看該作者
39#
發(fā)表于 2025-3-28 06:35:25 | 只看該作者
Bacteremia After Liver Transplantation; Few Issues in Selection of Antibiotics for Treatment and Prs. Bacteremia represents “invasive” infection and knowing the common agents involved helps in selection of antibiotics for treatment and prophylaxis. Successful use of antibiotics requires familiarity with their characteristics, potential side effects and interactions with other medications.
40#
發(fā)表于 2025-3-28 10:47:10 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 14:45
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
连南| 南投县| 分宜县| 名山县| 安平县| 大姚县| 遵义市| 翁源县| 利川市| 沧州市| 靖边县| 怀远县| 汉沽区| 白玉县| 木里| 新宁县| 松溪县| 沙田区| 湘乡市| 策勒县| 南充市| 闽侯县| 富蕴县| 绥芬河市| 灵台县| 利辛县| 大关县| 永康市| 西城区| 武平县| 霍林郭勒市| 汉寿县| 贵定县| 吐鲁番市| 繁昌县| 逊克县| 庆元县| 锡林浩特市| 习水县| 八宿县| 弥渡县|